Slide 1: Submission of Investor Presentation to Stock Exchanges
Date: October 29, 2025 To, To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C/1, G-Block Dalal Street Mumbai - 400 001 Bandra-Kurla Complex Scrip Code:544282
Slide 2: Investor Deck – Q2 FY26
October 29, 2025 Investor Deck – Q2 FY26
Slide 3: Safe Harbour
Safe Harbour Certain statements in this release concerning Sagility’ future growth prospects may be seen as forward- looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. Sagility does not undertake to update any
Slide 4: Performance Highlights
Performance Highlights Q2 FY26 summary H1 FY26 summary ► 16.0% Y-o-Y organic growth in Q2 FY26 driven by expansion from existing clients, while new wins are expected to further strengthen momentum in H2 ► $34 M (potential steady state ACV) of new business & expansion won in Q2 FY26 ₹ 31,974 ₹ 8,039
Slide 5: KPIs
KPIs Q2 FY26 Q1 FY26 Q2 FY25 YoY% H1 FY26 H1 FY25 YoY% Revenue from Operation (in INR Million) 16,585 15,389 13,250 25.2% 31,974 25,484 25.5% Revenue by Vertical Split By Payer % 88.5% 88.4% 89.2% 88.4% 89.2% By Provider % 11.5% 11.6% 10.8% 11.6% 10.8% Growth in revenue from operation (%) 25.2% 25.8
Slide 6: Annual KPIs
Annual KPIs H1 FY26 FY25 FY24 FY23 Number of Client groups* Active 82 75 44 35 Number of new client addition (Gross) 9 38 13 7 Delivery sites Number of delivery sites 34 33 30 27 New site addition (Gross) 3 10 4 2 TTM Sept 25 FY25 FY24 FY23 Client groups contribution to revenues Top 3 Client % 63.1%
Slide 7: Recent Market Updates
Recent Market Updates Market Changes Impact on Payer/ Provider Likely Impact on Sagility Normalization of tariffs as a long-term ► Tariff driven increase in cost of imported medical ► No tangible impact policy measure equipment & Pharmaceuticals. Providers more exposed to Tariff risks than payers. M
Slide 8: Larger and more complex deal constructs
Larger and more complex deal constructs Transform in place Transform and elevate Engagement Revenue Growth through bundled technology and services For a large national player, traditional levers A large regional payer wanted to achieve substantial A leading national payer providing B2B services like
Slide 9: Sagility Thought Leadership
Sagility Thought Leadership What’s New & What’s Next for 2025 Case Studies & White Papers Solution Videos Events & Expert Talks One Big Beautiful Bill Act AI-enabled Virtual Agent AHIP Webinar – September Highest registration AHIP has had in 2025 AHIP Webinar – October Featuring insights and deploye
Slide 10: Financial Highlights
Financial Highlights
Slide 11: Financial Highlights
Financial Highlights Q2 FY26 H1 FY26 ₹ 16,585 ₹ 4,352 ₹ 3,010 ₹ 2,374 ₹ 31,974 ₹ 8,039 ₹ 5,007 ₹ 5,585 million million million million million million million million Y-o-Y growth Y-o-Y growth 25.2% Margin % Margin % Conversion % 25.5% Margin % Margin % Conversion % 20.0 % at Constant 26.2% 18.1% 50
Slide 12: Quarterly Seasonality
Quarterly Seasonality Headcount 36.5 36.6 35.0 35.9 38.4 (‘000) Revenue ($M)18,000 $131.9 $150.8 $154.4 $146.6 $157.9 50.0% 16,000 45.0% 14,000 ₹12,602 ₹12,832 ₹13,250 40.0% ₹12,233 12,000 ₹10,941 35.0% June 23 to 30.0% 10,000 Sep 24 25.0% 8,000 26.1% 24.5% 23.8% 20.0% 6,000 22.6% 23.0% 15.0% 4,000
Slide 13: Long Term Financial performance snapshot
Long Term Financial performance snapshot Revenue FY25 YoY% TTM Sep YoY% Adjusted EBITDA * FY25 YoY% TTM Sep YoY% Adjusted PAT FY25 YoY% TTM Sep YoY% (INR Million) 17.2% 22.1% (INR Million) 28.4% 31.5% (INR Million) 37.5% 59.2% ₹62,190 ₹55,699 ₹16,343 ₹10,031 ₹47,536 ₹50,917 ₹14,685 ₹8,107 ₹11,436 ₹1
Slide 14: Other Financial Indicators
Other Financial Indicators Adjusted EPS (in INR) Adjusted ROCE % 2.15 54.9% 54.8% 1.76 1.38 47.0% FY24 FY25 TTM Sep 25 FY24 FY25 TTM Sep 25 Cash Conversion (%) Net Debt 87.2% 89.7% 80.5% ₹25,000 ₹21,678 2.50 70.8% 67.3% ₹20,000 2.00 57.6% ₹15,000 1.9x 1.50 ₹10,433 ₹10,000 ₹6,199 1.00 ₹5,000 0.71x 0.
Slide 15: Q2 FY26 Consolidated Profit and Loss
Q2 FY26 Consolidated Profit and Loss Amt in INR M Particulars Q2 FY26 Q1 FY26 Q2 FY25 YoY% QoQ% H1 26 H1 25 YoY% Revenue from Operation 16,585 15,389 13,250 25.2% 7.8% 31,974 25,484 25.5% Employee benefits expense* 10,070 9,646 7,912 19,715 15,439 Other expenses^ 2,163 2,056 1,874 4,220 3,664 Adjust
Slide 16: Adjustments on EBITDA and PAT
Adjustments on EBITDA and PAT Adj EBITDA Bridge: Q2 FY26 Adj EBITDA Bridge: H1 FY26 INR Million INR Million ₹4,733 ₹127 ₹73 ₹4,352 -₹582 ₹8,293 ₹283 ₹145 ₹8,039 -₹681 Reported Reported EBITDA Adj A Adj B Other Other income/ Income/Fx gain Adjusted EBITDA Reported Reported EBITDA Adj A Adj B Other Ot
Slide 17: Go Forward Positions
Go Forward Positions Amt in INR M Particulars FY25 FY26 FY27 FY28 FY29 FY30 Closing Debt position 8,020 5,670 Debt Repayment 2,490 2,350 5,670 Interest Payment 751 535 285 Share based Payment awards 1,134 255 151 80 41 Earnouts Cost - DCI / Birch/ BroadPath 571 503 5 Intangibles Amortisation (A) 1,4
Slide 18: Balance Sheet - 30th September 25
Balance Sheet - 30th September 25 Amt in INR M Particulars Sep 25 Mar 25 Property, plant and equipment 3,946 3,699 Capital-work-in-progress 4 0 Right-of-use assets 4,987 5,521 Goodwill 61,666 60,390 Other intangible assets 20,161 20,362 Trade receivables and Unbilled 14,224 12,668 Cash and cash equi
Slide 19: Cash Flow – H1 FY26
Cash Flow – H1 FY26 Amt in INR M Particulars H1 FY26 FY25 Profit before tax for the period/ year 5,372 7,602 Adjustment for Non-Operating and Non-Cash items 2,362 6,982 Adjustment for working capital (309) (710) Income taxes paid (net of refunds) (1,840) (1,734) Net cash flows generated from operati
Slide 20: Thank You
Thank You